Moors & Cabot Inc. Has $756,000 Stake in Intuitive Surgical, Inc. $ISRG

Moors & Cabot Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.3% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,392 shares of the medical equipment provider’s stock after purchasing an additional 225 shares during the quarter. Moors & Cabot Inc.’s holdings in Intuitive Surgical were worth $756,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Nuveen LLC bought a new stake in Intuitive Surgical during the first quarter valued at $1,715,899,000. Goldman Sachs Group Inc. lifted its stake in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after purchasing an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares in the last quarter. Jennison Associates LLC grew its stake in Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after purchasing an additional 528,359 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 2.2%

Shares of Intuitive Surgical stock opened at $560.00 on Friday. The company has a market cap of $200.75 billion, a PE ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a 50 day moving average price of $471.89 and a 200-day moving average price of $500.87.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ISRG shares. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Argus boosted their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Finally, BTIG Research increased their price target on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,193 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 98,078 shares of company stock valued at $51,445,892 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.